Skip to content
10-Q

Quarterly Report

CEN BIOTECH, INC.

0001437749-21-027166

← back to feed
Filed
Nov 19, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 19, 2021 52.81M sh
Short Term Debt Q3 2021 · Sep 30, 2021 $1.99M
Short Term Debt Q3 2021 · Dec 31, 2020 $527.38K
Cash And Equivalents Q3 2021 · Sep 30, 2021 $213.81K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $1.91K
Current Liabilities Q3 2021 · Sep 30, 2021 $10.87M
Current Liabilities Q3 2021 · Dec 31, 2020 $14.71M
Total Liabilities Q3 2021 · Sep 30, 2021 $11.48M
Total Liabilities Q3 2021 · Dec 31, 2020 $16.31M
Current Assets Q3 2021 · Sep 30, 2021 $396.91K
Current Assets Q3 2021 · Dec 31, 2020 $19.81K
Total Assets Q3 2021 · Sep 30, 2021 $8.4M
Total Assets Q3 2021 · Dec 31, 2020 $6.31M
Revenue Q3 2021 · Jul 8, 2021 $0
Revenue Q3 2021 · Sep 30, 2020 $0
Revenue Q3 2021 · Sep 30, 2020 $0
Stockholders Equity Q3 2021 · Dec 31, 2020 −$9.99M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$29.35M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$27.82M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$25.54M
Capex Q3 2021 · Sep 30, 2020 $0
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$399.31K
Sga Expense Q3 2021 · Sep 30, 2020 $268.49K
Sga Expense Q3 2021 · Sep 30, 2020 $871.91K
Net Income Q3 2021 · Sep 30, 2020 −$1.93M
Net Income Q3 2021 · Sep 30, 2020 −$4.89M
Operating Income Q3 2021 · Sep 30, 2020 −$968.42K
Operating Income Q3 2021 · Sep 30, 2020 −$2.19M